Literature DB >> 17496576

New guidelines for the management of adult community-acquired pneumonia.

Kathryn Armitage1, Mark Woodhead.   

Abstract

PURPOSE OF REVIEW: Community-acquired pneumonia is a major cause of morbidity and mortality, and is the leading cause of death from an infectious disease. International societies have published and revised guidelines aiming to improve the management of adult community-acquired pneumonia, based on the best available evidence. The aim of this review is to compare the current guideline recommendations. RECENT
FINDINGS: Aspects of guidelines differ based on local factors including resources and antimicrobial factors, as well as the differences in interpretation of existing evidence.
SUMMARY: The lack of robust evidence behind aspects of guideline recommendations as well as the lack of adherence to published guidelines both need to be addressed if the management of community-acquired pneumonia is to be improved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496576     DOI: 10.1097/QCO.0b013e3280803d70

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  8 in total

1.  Risk factors for mortality in cirrhotic patients with sepsis.

Authors:  Lee-Guan Lim; Xiang-Xuan Eunice Tan; Shu-Jeng Woo; Yock-Young Dan; Yin-Mei Lee; Vincent Lai; Seng-Gee Lim
Journal:  Hepatol Int       Date:  2011-02-13       Impact factor: 6.047

Review 2.  The diagnosis of pneumonia requires a chest radiograph (x-ray)-yes, no or sometimes?

Authors:  Dan Wootton; Charles Feldman
Journal:  Pneumonia (Nathan)       Date:  2014-06-19

3.  Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins.

Authors:  J Pradelli; K Risso; F G de Salvador; E Cua; R Ruimy; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-02       Impact factor: 3.267

4.  Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.

Authors:  Steven J Edwards; Sarah Wordsworth; Mike J Clarke
Journal:  Eur J Health Econ       Date:  2011-01-18

5.  An unusual infection on an unusual gastroenteritis.

Authors:  Christos Zavos; Dimitrios N Samonakis; Jean-Marie Enele Melono; Argyro Voloudaki; John Grammatikakis; Elias A Kouroumalis
Journal:  Ann Gastroenterol       Date:  2011

6.  Application of vibration response imaging technology in patients with community-acquired pneumonia before and after the treatment.

Authors:  Hongying Jiang; Jichao Chen; Jinying Cao; Lan Mu; Zhenyu Hu; Jian He
Journal:  Exp Ther Med       Date:  2017-05-03       Impact factor: 2.447

Review 7.  Epidemiology, etiology, x-ray features, importance of co-infections and clinical features of viral pneumonia in developing countries.

Authors:  Miguel Lanaspa; Alicia A Annamalay; Peter LeSouëf; Quique Bassat
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

8.  Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India.

Authors:  Anita Kotwani; Santosh Kumar; Prafulla Kumar Swain; J C Suri; S N Gaur
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.